Schroders Capital logo

Schroders Capital

Europe, England, United Kingdom, London

Description

Schroders Capital helps the clients with the management of the investments.

Investor Profile

Schroders Capital has backed more than 30 startups, with 10 new investments in the last 12 months alone. The firm has led 6 rounds, about 20% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (20%)
  • Series C (20%)
  • Series B (17%)
  • Debt Financing (13%)
  • Series Unknown (10%)
  • Series D (3%)
  • Series E (3%)
  • Seed (3%)
  • Post Ipo Equity (3%)
  • Post Ipo Debt (3%)

Country Focus

  • United States (27%)
  • United Kingdom (23%)
  • Switzerland (20%)
  • The Netherlands (13%)
  • France (3%)
  • India (3%)
  • Canada (3%)
  • Luxembourg (3%)
  • Australia (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Renewable Energy
  • Pharmaceutical
  • Medical
  • Elder Care
  • Home Health Care
  • Mobile Apps
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Schroders Capital frequently co-invest with?

EC
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 3
UI
North America, California, United States, Oakland
Co-Investments: 3
Inovia Capital
North America, Quebec, Canada, Montréal
Co-Investments: 2
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 3
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Pureos Bioventures
Europe, Zurich, Switzerland, Küsnacht
Co-Investments: 3
The Column Group
North America, California, United States, San Francisco
Co-Investments: 4
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2

Which angels does Schroders Capital often collaborate with?

DV
Europe, Zuid-Holland, The Netherlands, Rotterdam
Shared Deals: 1
ES
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
RK
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Schroders Capital?

Sylvan

Kittanning, Pennsylvania, United States

Sylvan manufactures and distributes a wide range of mushrooms, spawns and strains for companies across the world.

AgricultureClinical TrialsManufacturing
Private EquityJan 21, 2026
Kinaset Therapeutics

Boston, Massachusetts, United States

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Health CareMedicalTherapeutics
Series BJan 10, 2026
Amount Raised: $103,000,000
MoEngage

San Francisco, California, United States

MoEngage is an internet company that features cloud-based marketing services for consumer businesses.

AnalyticsDigital MarketingInformation TechnologyMarketing AutomationSaaS
Series FDec 17, 2025
Amount Raised: $57,000,000
MoEngage

San Francisco, California, United States

MoEngage is an internet company that features cloud-based marketing services for consumer businesses.

AnalyticsDigital MarketingInformation TechnologyMarketing AutomationSaaS
Secondary MarketDec 16, 2025
Amount Raised: $123,000,000
Artios Pharma

Cambridge, Cambridgeshire, United Kingdom

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

BiopharmaBiotechnologyMedical Device
Series DNov 17, 2025
Amount Raised: $115,000,000
AAVantgarde Bio

Milano, Lombardia, Italy

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BNov 3, 2025
Amount Raised: $141,000,000
Indaqua

Vila Do Conde, Porto, Portugal

Indaqua specializes in the treatment, supply, and management of water and wastewater.

ConsultingEnvironmental EngineeringInfrastructureWaterWater Purification
Debt FinancingSep 11, 2025
Amount Raised: $418,804,559
Draig Therapeutics

Cardiff, New South Wales, Australia

Draig Therapeutics is a clinical-stage biopharmaceutical startup.

BiotechnologyTherapeutics
Series AJun 18, 2025
Amount Raised: $140,000,000
Azafaros

Leiden, Zuid-Holland, The Netherlands

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BMay 13, 2025
Amount Raised: $146,690,300
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series AMay 8, 2025
Amount Raised: $65,000,000

Find More Investors Like Schroders Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Schroders Capital | Pipeseed